As a result, most Megadeth shows for this year will be canceled.
"I’ve been diagnosed with throat cancer. It’s clearly something to be respected and faced head on - but I’ve faced obstacles before. I’m working closely with my doctors, and we’ve mapped out a treatment plan which they feel has a 90 percent success rate. Treatment has already begun," Mustaine, 57, shared with fans.
"Unfortunately, this requires that we cancel most shows this year. The 2019 Megacruise will happen, and the band will be a part of it in some form. All up to date information will be at megadeth.com as we get it. Megadeth will be back on the road ASAP." – which I can’t wait for everyone to hear. I’m so thankful for my whole team – family, doctors, band members, trainers, and more," he continued.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Megadeth's Dave Mustaine Diagnosed with Throat CancerMegadeth frontman Dave Mustaine shared with fans on Monday (June 17) that he has been diagnosed with throat cancer and that he and his doctors feel his treatment plan could have a '90 % success rate.'
Read more »
Megadeth's Dave Mustaine says he has throat cancerCNN News, delivered. Select from our newsletters below and enter your email to subscribe.
Read more »
Dave Bautista on Standing By James Gunn After 'Guardians' FiringThe leading man also chats about acting alongside Karen Gillan outside of the MCU.
Read more »
Slideshow: Conditions That Are Hard to DiagnoseWhen your thyroid makes too much of the hormone thyroxine, it causes hyperthyroidism. You may be nervous, anxious, or irritable, and that can seem like a mood disorder.
Read more »
I Was Diagnosed With a Rare Autoimmune Liver Disease Before I Had Any Symptoms | HealthyWomenRead Tina's story about how she lives well with primary biliary cholangitis (PBC) by being an expert on her symptoms, labs and new “normal,” all while working with her team of health care professionals: realwomenrealstories
Read more »
Pfizer to Buy Cancer Drug Maker Array BioPharma for $10.64 BillionPfizer agreed to buy Array BioPharma for $10.64 billion in cash, as the pharmaceutical company looks to expand its pipeline of cancer therapies.
Read more »